Levetiracetam use and pregnancy outcome
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Reproductive Toxicology
- Vol. 20 (1) , 175-178
- https://doi.org/10.1016/j.reprotox.2004.12.001
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Levetiracetam treatment of idiopathic generalised epilepsySeizure, 2003
- Serum Concentrations of Levetiracetam in Epileptic Patients: The Influence of Dose and Co-medicationTherapeutic Drug Monitoring, 2003
- Drug points: Weight loss associated with levetiracetamBMJ, 2003
- Developmental Outcome of Levetiracetam, Its Major Metabolite in Humans, 2‐Pyrrolidinone N‐Butyric Acid, and Its Enantiomer (R)‐α‐ethyl‐oxo‐pyrrolidine Acetamide in a Mouse Model of TeratogenicityEpilepsia, 2003
- Levetiracetam monotherapy during pregnancy: a case seriesEpilepsy & Behavior, 2003
- A systematic review of the safety profile of levetiracetam: a new antiepileptic drugEpilepsy Research, 2001
- Use of Levetiracetam in Special PopulationsEpilepsia, 2001
- Pharmacokinetic Considerations in Prescribing Antiepileptic DrugsEpilepsia, 2001
- Antiepileptic drug regimens and major congenital abnormalities in the offspringAnnals of Neurology, 1999
- Effect of age, parity, and smoking on pregnancy outcome: A population-based studyAmerican Journal of Obstetrics and Gynecology, 1993